Siberian hamsters (Phodopus sungorus) undergo bouts of daily torpor during which body temperature decreases by as much as 20°C and provides a significant savings in energy expenditure. Natural torpor in this species is normally triggered by winter-like photoperiods and low ambient temperatures. Intracerebroventricular injection of neuropeptide Y (NPY) reliably induces torpor-like hypothermia that resembles natural torpor. NPY-induced torpor-like hypothermia is also produced by intracerebroventricular injections of an NPY Y1 receptor agonist but not by injections of an NPY Y5 receptor agonist. In this research, groups of cold-acclimated Siberian hamsters were either co-injected with a Y1 receptor antagonist (1229U91) and NPY or were co-injected with a Y5 receptor antagonist (CGP71683) and NPY in counterbalanced designs. Paired vehicle + NPY induced torpor-like hypothermia in 92% of the hamsters, whereas co-injection of Y1 antagonist + NPY induced torpor-like hypothermia in 4% of the hamsters. In contrast, paired injections of vehicle + NPY and Y5 antagonist + NPY induced torpor-like hypothermia in 100% and 91% of the hamsters, respectively. Although Y5 antagonist treatment alone had no effect on body temperature, Y1 antagonist injections produced hyperthermia compared to controls.
4 amphetamine-related transcript (8, 12 ) and co-localizing ARC leptin receptors (1) A primary function of arcuate nucleus leptin/NPY-ergic mechanisms may be to conserve white adipose tissue reserves by reducing energy expenditure during energetic challenges (16, 57). During such challenges, reduced leptin concentrations disinhibit ARC NPY neurons, increasing turnover and release of NPY (1, 55) . NPY may be a powerful orexigenic neurotransmitter, but it also has the capacity to decrease metabolism (e.g., Ref. 35 ). For example, intracerebroventricular (ICV) injections of NPY in rats decrease thermogenesis by completely suppressing sympathetic neural input to brown adipose tissue (BAT) (14), decreasing BAT thermogenic activity (GDP binding) (5, 58) , reducing whole-body metabolic rate (58) , and, consequently, lowering T b (29) .
NPY injected ICV reliably decreases T b in warm-and cold-acclimated homeothermic laboratory rats by 1-3°C (e.g., Refs. 7, 28, 53, 54) . Cold-acclimated heterothermic Siberian hamsters, on the other hand, decrease T b by as much as 20°C for as long as 18 h after comparable ICV injections of NPY (42, 45) . Temperature records during NPY-induced torpor-like hypothermia resemble those during natural torpor (42) The neurotransmitter (or neuromodulator), NPY, is a 36 amino acid peptide for which 6 possible G-protein receptor subtypes have been identified: Y1, Y2, Y3, Y4, Y5, and y6 (e.g., Refs. 1, 27). Studies in laboratory mice and rats using Y1 and Y5 receptor agonists, antagonists, and/or genetic knock-out animals suggest that both receptor subtypes contribute to NPY-induced food intake (27, 41, 43) . In Siberian hamsters, NPY injected ICV reliably increases short-term (1-4 h) food intake (6, 45) , but Y1 and Y5 receptor agonists can at best be described as inconsistently affecting short-term food intake (11, 45). Siberian hamsters, on the other hand, markedly increased food hoarding after either an ICV injection of NPY or of a Y1 receptor agonist; central Y5 agonist treatment did not affect hoarding (11).
Intracerebroventricularly injected NPY that produces mild hypothermia in the homeothermic rat induces marked torpor-like hypothermia in heterothermic Siberian hamsters (42) . Because both ICV injected NPY and an NPY Y5 agonist comparably reduced interscapular BAT temperature (T IBAT ) in warm-acclimated rats whereas neither a Y1, Y2, nor Y4 agonist effected T IBAT (26) , we predicted that NPY-induced torpor-like hypothermia would most likely be mediated by activation of the NPY Y5 receptor site. The purpose of this research was to determine whether activation of the Y1 receptor subtype solely underlies the capacity of NPY to trigger torpor-like hypothermia.
If NPY acting at the Y1 receptor site is necessary, then co-injection of a Y1 receptor antagonist with NPY should prevent the initiation of torpor-like hypothermia. In addition, if activation of the Y5 receptor site by NPY is truly unnecessary for torpor-like hypothermia initiation, then injection of a Y5 receptor antagonist immediately prior to NPY treatment should not prevent induction of torpor-like hypothermia. To test this, 1 group of cold-acclimated Siberian hamsters was tested with the Y1 receptor antagonist, 1229U91 (GR231118), and another group of hamsters was tested with the Y5 receptor antagonist, CGP71683A. Each group of hamsters received 4 different paired treatments over the course of 4 weeks in a counterbalanced design. Body temperature data were analyzed for minimum T b and duration of torpor-like hypothermia, if present, and 24 h food intake was calculated.
MATERIALS AND METHODS
This research was carried out in laboratory facilities approved by the Association for the Assessment and Accreditation of Laboratory Animal Care. All procedures were approved by the Animal Care and Use Committee of the University of California at Berkeley and conform to the standards established by the National Institutes of Health.
Animals
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7 Fifty-two adult female Siberian hamsters reared in a photoperiod (14L:10D) with a long photophase (LP) and T a = 22°C were housed individually in polypropylene tub cages (12.5 x 8.0 x 5.5 cm) with Care Fresh Bedding (Harlan, San Diego) and provided water and food (Lab Diet, #5015) ad lib, except where described otherwise.
Surgical procedures
After 3 weeks of cold-acclimation to T a = 10°C, all hamsters were deeply anesthetized with a ketamine-based anesthetic (0.34 ml/kg body mass, ip, containing 21 mg ketamine + 2.4 mg xylazine + 0.3 mg acepromazine/ml) to undergo a single surgery in which an ICV guide cannula was implanted intracranially and a telemetric temperature transmitter was implanted intra-abdominally. In an initial procedure, a 26 gauge guide cannula was stereotaxically lowered to just above the 3rd ventricle using the following coordinates: 0.0 mm anterior to bregma, 0.0 mm lateral to the midsagittal line, and 5.5 mm ventral to dura. The cannula was fixed to the skull with cyanoacrylate glue, stainless steel screws, and dental acrylic. A stainless steel stylet remained in the cannula, except during injections, to maintain patency. The wound was sutured shut with sterile sutures, if necessary.
With completion of the cannula implantation, the abdomen was shaved, a midline incision made, and a transmitter inserted into the peritoneal cavity. The peritoneum and skin were closed with sterile sutures. At the completion of surgery, the hamsters received an injection of 0.1 ml buprenorphine (0.015 mg/ml) to provide postsurgical For the intracerebroventricular injection procedure, the stylet was removed from the guide cannula and a 33 gauge injection cannula was lowered until it extended 1.0 mm beyond the guide cannula. A Hamilton microsyringe was connected to the injection cannula with polyethylene tubing and the injectate slowly injected over 30 sec. The injection cannula was then left in place for ~30-45 sec to minimize reflux before it was removed and the stylet returned to the guide cannula. were also analyzed for the proportion of animals entering torpor-like hypothermia subsequent to treatments.
Body temperature measurements and torpor criterion
Procedures
The adult Siberian hamsters were moved into an environmental chamber with the same LP in which they had been reared but T a was lowered to 10°C. The hamsters were allowed to acclimate to the new temperature for 3 weeks. The hamsters were weighed and divided into 2 weight-balanced groups: 1 for testing the NPY Y1 receptor antagonist (1229U91; n = 28) and the other for testing the NPY Y5 receptor antagonist (CGP71683A; n = 24). All injections were made within the 1st 1-3 h of the light (rest) phase when natural torpor normally occurs.
NPY Y1 receptor antagonist treatments. All food was removed from the animals
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10 cages ~1 h after light onset and injections were begun at this time. In the first week, ¼ of the hamsters were injected ICV with 1229U91 then were immediately injected ICV with NPY (Y1Ant + NPY group), the next ¼ was injected ICV with saline then immediately injected ICV with NPY (Sal + NPY group), the 3rd ¼ was injected ICV with 1229U91 and then saline (Y1Ant + Sal group), and the final ¼ was injected ICV with saline and then given another ICV saline injection (Sal + Sal group) (see, Table 1 ). In the successive 3 weeks, the treatments were repeated in a counterbalanced design such that each hamster received each treatment pairing (Table 1) . Upon completion of a pair of injections, the hamster was immediately returned to its cage and T b measurements continued. A preweighed amount of food was provided to each hamster's cage at the end of the light phase, ~8 h later, after the likely termination of any NPY-induced torpor-like hypothermia. The food was reweighed 24 h from the time of treatment and intake was calculated.
NPY Y5 receptor antagonist treatments. This same design was repeated with the hamsters receiving Y5 antagonist treatments (see, Table 1 ). Approximately 1 h after light onset, food was removed from the animals' cages and treatments begun. In the first week, ¼ of the hamsters were injected ip with CGP71683A then were injected ICV with NPY (Y5Ant + NPY group), the 2nd ¼ was injected ip with DMSO vehicle and then ICV with NPY (DMSO + NPY group), another ¼ received CGP71683A injected ip and saline injected ICV (Y5Ant + Sal group), and the final ¼ was injected ip with DMSO vehicle and ICV with saline (DMSO + Sal group). All animals received all treatments in a counterbalanced design over 4 weeks ( Table 1 ). The animals were immediately returned to their cages after treatment, and T b and 24 h food intake measurements were Page 10 of 41 11 performed as above.
Histological procedures
The hamsters were administered a lethal injection of pentobarbital sodium (euthanasia solution) with the completion of testing. While the animals were deeply anesthetized, India ink was injected through the injection cannula and the hamsters were transcardially perfused with 0.1 M phosphate buffered saline (PBS) followed by buffered formalin. The brain was removed and stored in buffered formalin until frozen coronal sections (40 µm) were cut, mounted on prepared slides, stained with cresyl violet, and coverslipped. Locus of cannula termination and presence/absence of India ink in 3rd ventricle were verified by 2 observers.
Statistical analysis
The proportion of hamsters undergoing torpor-like hypothermia after Y1 or Y5 hypothermia was determined by linear regression. Statistics were performed using the SigmaStat 3.0 program (SPSS). All differences were considered statistically significant if P < 0.05. Precise P values are given in accordance with APS Guidelines for Authors.
RESULTS
Histology
Twenty-seven of the hamsters in the Y1 receptor antagonist group and 24 of the hamsters in the Y5 receptor antagonist group had cannulae verified as terminating in the 3rd ventricle. Hamsters in which the cannulae did not successfully terminate in the 3rd ventricle were not considered in the analyses.
NPY Y1 receptor antagonist treatments
The various treatment pairings significantly affected the proportion of Siberian hamsters entering torpor-like hypothermia (Chi-square = 90.4, P < 0.1·10 -15 ; Fig. 1 ).
Co-injection of Sal + Sal or Y1Ant + Sal induced torpor-like hypothermia in 0% of the hamsters. Injection of Sal + NPY initiated torpor-like hypothermic bouts in 92.3% of the hamsters (Fig. 2) . Co-injection of Y1Ant + NPY, on the other hand, induced torpor-like hypothermia in 1 of 28 hamsters (3.8%; Fig. 2 ). There was also a significant effect of treatment on T b min (F = 75.5, P < 0.1·10 -15 ; Table 2 ; Table 3 ). The maximum T b of the hamsters receiving the Y1Ant + Sal treatment was significantly greater than that of the vehicle + vehicle controls (P = 0.0002; Table 3 ).
Unplanned observations of the Siberian hamsters co-injected with Y1Ant + NPY revealed very unusual patterns of behavior, which were characterized by rapid breathing and shivering and limb twitching. They either lied on their back with their dorsum exposed or underwent 'shaky and wobbly' walking. Although hamsters treated with Y1Ant + Sal also exhibited rapid breathing and some shivering, they typically assumed the curled-up posture characteristic of torpor even though they were not hypothermic.
Twenty-four hour food intake was significantly affected by NPY Y1 receptor antagonist treatments (F = 47.2, P < 0.1·10 -15 ; Fig. 3 ). The Y1 antagonist significantly reduced 24 h intake. The Y1Ant + Sal and the Y1Ant + NPY treatment pairing groups both reduced consumption compared to the Sal + Sal or Sal + NPY treatments (P = 0.0002, for all; Fig. 3 ). Food intake of the Y1Ant + Sal group did not differ from that of Y1Ant + NPY treated hamsters (P = 0.50).
Twenty-four hour food ingestion of hamsters co-injected with Sal + NPY did not differ from that of Sal + Sal injected controls (P = 0.47, Fig. 3 ). Food intake of hamsters after undergoing torpor-like hypothermia due to Sal + NPY treatment also did not vary 
NPY Y5 receptor antagonist treatments
The proportions of hamsters entering torpor-like hypothermia were affected by the different treatment pairings (Chi-square = 87.7, P < 0.1·10 -15 ; Fig. 1 ). Neither coinjection of DMSO + Sal nor Y5Ant + Sal produced torpor-like hypothermia (0%, for both). 100% of the hamsters treated with DMSO + NPY entered torpor-like hypothermia and 91.3% of the hamsters receiving Y5Ant + NPY underwent torpor-like hypothermic bouts (Fig. 4) . T b min was significantly affected in the 4 treatment groups (F = 220.8, P < 0.1·10 -15 ; Table 4 ). With the exception of the DMSO + Sal vs. Y5Ant + Sal group comparison (P = 0.24), all pair-wise comparisons were significantly different, including DMSO + NPY vs. Y5Ant + NPY (P = 0.0003, for all; Table 4 ). Similarly, when comparing only those animals entering torpor-like hypothermia in the latter 2 pairings, there was a significant difference in T b min during torpor-like hypothermia (t-test = 2.7, P = 0.011; Table 4 ) and in torpor-like hypothermia duration (t-test = 3.4, P = 0.002; Table   4 ).
Maximum T b during the 1 h following Y5 antagonist treatments (Y5Ant + Sal) did not differ from that of vehicle + vehicle controls (P = 0.27, Table 3 ) but was significantly less than the maximum T b of Y1 antagonist treated hamsters (P = 0.0002, Table 3 A Y1 receptor antagonist (1229U91) injected ICV similarly inhibits feeding after an overnight fast (31) , and Y1 receptor antisense oligodeoxynucleotide treatments impair the increased energy intake after overnight fasting (51). Although refeeding after either food restriction or fasting is comparatively limited in Siberian hamsters, food-restriction or an ICV injection of Y1 agonist significantly increases foraging and hoarding (11). ICV injection of a Y1 antagonist inhibited food intake and foraging induced by fasting but, surprisingly, had a less pronounced effect on hoarding (32). The NPY Y1 receptor also apparently contributes to the delayed puberty due to reduced energy intake (e.g., Refs. 
